The addition of Prof. Jay Shendure as its newest Scientific Co-Founder is great news for the company.
Prof. Shendure, an HHMI Investigator and world leader in single-cell and functional genomic assays, has pushed the envelope on the scale of analyses that are possible today.
Prof. Shendure, an HHMI Investigator and world leader in single-cell and functional genomic assays, has pushed the envelope on the scale of analyses that are possible today.
His addition to the team will help Somite advance its platform, AlphaStem, to develop cell replacement therapies for diseases such as diabetes, obesity, and muscular dystrophies.
The company's plan is to generate massive amounts of data to lay the foundation of their platform, Alphastem.
About Prof. Jay Shendure.
Jay Shendure is an investigator of the Howard Hughes Medical Institute, a professor of genome sciences at the University of Washington, and the Scientific Director of the Seattle Hub for Synthetic Biology.
Somite is about.
Somite.ai is a venture-backed company aiming to become the OpenAI of stem cell biology, developing artificial intelligence foundation models to produce human tissue for cell therapies at scale for diseases such as diabetes, obesity, and muscular dystrophies.
Somite.ai has raised $5.3m to date.
The management team of somite.
Scientific co-founders:
Email protected, Website: www.somite.ai
SomiteTherapeutics is the source of this information.
SomiteTherapeutics, a tech-bio company using big data and artificial intelligence to introduce novel cell replacement therapies, today announced...
Somite has raised $5.3 million in pre-seed funding, which will be used to further develop the company.

Source prnewswire